Diagnostics for Infectious Diseases Using Gold Nanoparticles - Kimberly Hamad-Schifferli | Duke FIP

The global COVID-19 pandemic has underscored the need for innovations in disease diagnostics. The convergence of the fields of nanotechnology and medicine has resulted in new approaches for novel disease therapies, biomedical imaging and sensing, and numerous others. In particular, the use of gold nanoparticles in rapid diagnostics for infectious diseases has been emerging as an application with the potential to address some of the major challenges in global health. These assays are low-cost and can be used in rugged environments, so they are attractive for widespread deployment for disease surveillance, quarantining, and treatment.